Global Nocturnal Polyuria Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: G8EBDED6A881EN
QYResearch

Abstracts

Nocturnal Polyuria Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nocturnal Polyuria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Allergan
• Ferring Holding
• Teva Pharmaceutical Industries
• Urigen Pharmaceuticals
• Vantia Therapeutics
• Astellas Pharma
• ...

Market segment by Type, the product can be split into

• Antispasmodic
• Desmopressin
• Anticholinergic drugs
• Other

Market segment by Application, split into

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nocturnal Polyuria Treatment Revenue
1.4 Market by Type
  1.4.1 Global Nocturnal Polyuria Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antispasmodic
  1.4.3 Desmopressin
  1.4.4 Anticholinergic drugs
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Nocturnal Polyuria Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Online Pharmacy
  1.5.4 Retail Pharmacy
  1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Nocturnal Polyuria Treatment Market Perspective (2015-2026)
2.2 Global Nocturnal Polyuria Treatment Growth Trends by Regions
  2.2.1 Nocturnal Polyuria Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Nocturnal Polyuria Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Nocturnal Polyuria Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Nocturnal Polyuria Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Nocturnal Polyuria Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Nocturnal Polyuria Treatment Players by Market Size
  3.1.1 Global Top Nocturnal Polyuria Treatment Players by Revenue (2015-2020)
  3.1.2 Global Nocturnal Polyuria Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Nocturnal Polyuria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nocturnal Polyuria Treatment Market Concentration Ratio
  3.2.1 Global Nocturnal Polyuria Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Nocturnal Polyuria Treatment Revenue in 2019
3.3 Nocturnal Polyuria Treatment Key Players Head office and Area Served
3.4 Key Players Nocturnal Polyuria Treatment Product Solution and Service
3.5 Date of Enter into Nocturnal Polyuria Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Nocturnal Polyuria Treatment Historic Market Size by Type (2015-2020)
4.2 Global Nocturnal Polyuria Treatment Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Nocturnal Polyuria Treatment Market Size by Application (2015-2020)
5.2 Global Nocturnal Polyuria Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Nocturnal Polyuria Treatment Market Size (2015-2020)
6.2 Nocturnal Polyuria Treatment Key Players in North America (2019-2020)
6.3 North America Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
6.4 North America Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Nocturnal Polyuria Treatment Market Size (2015-2020)
7.2 Nocturnal Polyuria Treatment Key Players in Europe (2019-2020)
7.3 Europe Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
7.4 Europe Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Nocturnal Polyuria Treatment Market Size (2015-2020)
8.2 Nocturnal Polyuria Treatment Key Players in China (2019-2020)
8.3 China Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
8.4 China Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Nocturnal Polyuria Treatment Market Size (2015-2020)
9.2 Nocturnal Polyuria Treatment Key Players in Japan (2019-2020)
9.3 Japan Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
9.4 Japan Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Nocturnal Polyuria Treatment Market Size (2015-2020)
10.2 Nocturnal Polyuria Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Nocturnal Polyuria Treatment Market Size (2015-2020)
11.2 Nocturnal Polyuria Treatment Key Players in India (2019-2020)
11.3 India Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
11.4 India Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Nocturnal Polyuria Treatment Market Size (2015-2020)
12.2 Nocturnal Polyuria Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Nocturnal Polyuria Treatment Market Size by Type (2015-2020)
12.4 Central & South America Nocturnal Polyuria Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview
  13.1.3 Allergan Nocturnal Polyuria Treatment Introduction
  13.1.4 Allergan Revenue in Nocturnal Polyuria Treatment Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Ferring Holding
  13.2.1 Ferring Holding Company Details
  13.2.2 Ferring Holding Business Overview
  13.2.3 Ferring Holding Nocturnal Polyuria Treatment Introduction
  13.2.4 Ferring Holding Revenue in Nocturnal Polyuria Treatment Business (2015-2020)
  13.2.5 Ferring Holding Recent Development
13.3 Teva Pharmaceutical Industries
  13.3.1 Teva Pharmaceutical Industries Company Details
  13.3.2 Teva Pharmaceutical Industries Business Overview
  13.3.3 Teva Pharmaceutical Industries Nocturnal Polyuria Treatment Introduction
  13.3.4 Teva Pharmaceutical Industries Revenue in Nocturnal Polyuria Treatment Business (2015-2020)
  13.3.5 Teva Pharmaceutical Industries Recent Development
13.4 Urigen Pharmaceuticals
  13.4.1 Urigen Pharmaceuticals Company Details
  13.4.2 Urigen Pharmaceuticals Business Overview
  13.4.3 Urigen Pharmaceuticals Nocturnal Polyuria Treatment Introduction
  13.4.4 Urigen Pharmaceuticals Revenue in Nocturnal Polyuria Treatment Business (2015-2020)
  13.4.5 Urigen Pharmaceuticals Recent Development
13.5 Vantia Therapeutics
  13.5.1 Vantia Therapeutics Company Details
  13.5.2 Vantia Therapeutics Business Overview
  13.5.3 Vantia Therapeutics Nocturnal Polyuria Treatment Introduction
  13.5.4 Vantia Therapeutics Revenue in Nocturnal Polyuria Treatment Business (2015-2020)
  13.5.5 Vantia Therapeutics Recent Development
13.6 Astellas Pharma
  13.6.1 Astellas Pharma Company Details
  13.6.2 Astellas Pharma Business Overview
  13.6.3 Astellas Pharma Nocturnal Polyuria Treatment Introduction
  13.6.4 Astellas Pharma Revenue in Nocturnal Polyuria Treatment Business (2015-2020)
  13.6.5 Astellas Pharma Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Nocturnal Polyuria Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Nocturnal Polyuria Treatment Revenue
Table 3. Ranking of Global Top Nocturnal Polyuria Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nocturnal Polyuria Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antispasmodic
Table 6. Key Players of Desmopressin
Table 7. Key Players of Anticholinergic drugs
Table 8. Key Players of Other
Table 9. Global Nocturnal Polyuria Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Nocturnal Polyuria Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Nocturnal Polyuria Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Nocturnal Polyuria Treatment Market Share by Regions (2015-2020)
Table 13. Global Nocturnal Polyuria Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Nocturnal Polyuria Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Nocturnal Polyuria Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Nocturnal Polyuria Treatment Players
Table 20. Global Nocturnal Polyuria Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Nocturnal Polyuria Treatment Market Share by Players (2015-2020)
Table 22. Global Top Nocturnal Polyuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturnal Polyuria Treatment as of 2019)
Table 23. Global Nocturnal Polyuria Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nocturnal Polyuria Treatment Product Solution and Service
Table 26. Date of Enter into Nocturnal Polyuria Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Nocturnal Polyuria Treatment Market Size Share by Type (2015-2020)
Table 30. Global Nocturnal Polyuria Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Nocturnal Polyuria Treatment Market Size Share by Application (2015-2020)
Table 32. Global Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Nocturnal Polyuria Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 36. North America Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 38. North America Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 42. Europe Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 44. Europe Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 48. China Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 50. China Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 54. Japan Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 56. Japan Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 60. Southeast Asia Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 66. India Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 68. India Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Nocturnal Polyuria Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Nocturnal Polyuria Treatment Market Share (2019-2020)
Table 72. Central & South America Nocturnal Polyuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Nocturnal Polyuria Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Nocturnal Polyuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Nocturnal Polyuria Treatment Market Share by Application (2015-2020)
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan Product
Table 79. Allergan Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 80. Allergan Recent Development
Table 81. Ferring Holding Company Details
Table 82. Ferring Holding Business Overview
Table 83. Ferring Holding Product
Table 84. Ferring Holding Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 85. Ferring Holding Recent Development
Table 86. Teva Pharmaceutical Industries Company Details
Table 87. Teva Pharmaceutical Industries Business Overview
Table 88. Teva Pharmaceutical Industries Product
Table 89. Teva Pharmaceutical Industries Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 90. Teva Pharmaceutical Industries Recent Development
Table 91. Urigen Pharmaceuticals Company Details
Table 92. Urigen Pharmaceuticals Business Overview
Table 93. Urigen Pharmaceuticals Product
Table 94. Urigen Pharmaceuticals Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 95. Urigen Pharmaceuticals Recent Development
Table 96. Vantia Therapeutics Company Details
Table 97. Vantia Therapeutics Business Overview
Table 98. Vantia Therapeutics Product
Table 99. Vantia Therapeutics Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 100. Vantia Therapeutics Recent Development
Table 101. Astellas Pharma Company Details
Table 102. Astellas Pharma Business Overview
Table 103. Astellas Pharma Product
Table 104. Astellas Pharma Revenue in Nocturnal Polyuria Treatment Business (2015-2020) (Million US$)
Table 105. Astellas Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Nocturnal Polyuria Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antispasmodic Features
Figure 3. Desmopressin Features
Figure 4. Anticholinergic drugs Features
Figure 5. Other Features
Figure 6. Global Nocturnal Polyuria Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Nocturnal Polyuria Treatment Report Years Considered
Figure 12. Global Nocturnal Polyuria Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nocturnal Polyuria Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Nocturnal Polyuria Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nocturnal Polyuria Treatment Market Share by Players in 2019
Figure 17. Global Top Nocturnal Polyuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturnal Polyuria Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nocturnal Polyuria Treatment Revenue in 2019
Figure 19. North America Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nocturnal Polyuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed